IDT Up Over 8%, on Track for Record High Close -- Data Talk
Dow Jones2026/09/29 15:34IDT Corporation Class B (IDT) is currently at $75.50, up $5.94 or 8.53%
--Would be new all-time closing high (Based on available data back to May 10, 2001)
--On pace for largest percent increase since June 6, 2025, when it rose 14.39%
--Currently up two consecutive days; up 11.91% over this period
--Best two day stretch since the two days ending June 6, 2025, when it rose 16.58%
--Up 10.66% month-to-date; on pace for best month since July 2026, when it rose 13.24%
--Up 47.42% year-to-date
--Up 44.32% from 52 weeks ago (Sept. 30, 2025), when it closed at $52.31
--Would be a new 52-week closing high
--Up 61.87% from its 52-week closing low of $46.64 on Oct. 10, 2025
--Traded as high as $76.55; new all-time intraday high (Based on available data back to May 10, 2001)
--Up 10.05% at today's intraday high; largest intraday percent increase since June 6, 2025, when it rose as much as 16.14%
All data as of 11:31:26 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 29, 2026 11:34 ET (15:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results
Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.
Kroger (KR.US) faces the largest layoffs in 143 years: cutting one-third of positions, more than 3,000 employees to be let go
Kroger has laid off 3,000 employees, accounting for more than one-third of its total workforce, marking the largest layoff in its 143-year history. The resources saved will be redirected towards price reductions and frontline operations.
RBA Minutes: Case for rates to act promptly to keep inflation expectations anchored